Home » Topics » Regulatory

Regulatory
RSS

Velcade approved in Japan for primary macroglobulinemia and lymphoplasmacytic lymphoma

March 27, 2018

Hernicore approved in Japan to treat lumbar disc herniation

March 27, 2018

Japanese approval for Orkedia

March 27, 2018

Lenvima approved in Japan for unresectable HCC

March 26, 2018

European Commission approves Alofisel

March 26, 2018

FDA expands Tasigna indications for pediatric patients with CML

March 23, 2018

Lokelma receives E.U. approval for hyperkalemia

March 23, 2018

FDA approves Ilumya for moderate to severe plaque psoriasis

March 21, 2018

FDA approves CSL Behring's Hizentra in new indication

March 16, 2018

Solifenacin oral suspension for pediatric patients approved in Europe

March 12, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
FDA says yes to Cytokinetics’ aficamten, now Myqorzo, in oHCM
BioWorld
Cytokinetics Inc. scored U.S. FDA marketing clearance Dec. 19 for Myqorzo (aficamten) 5-mg, 10-mg, 15-mg, and 20-mg tablets to improve functional capacity and...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....